GB202109534D0 - Treatment of scarring - Google Patents

Treatment of scarring

Info

Publication number: GB202109534D0
Authority: GB; United Kingdom
Prior art keywords: scarring; treatment
Prior art date: 2021-07-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB2109534.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Anglia Ruskin Univ Higher Education Corp

Original Assignee

Anglia Ruskin Univ Higher Education Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2021-07-01

Filing date

2021-07-01

Publication date

2021-08-18

2021-07-01 Application filed by Anglia Ruskin Univ Higher Education Corp filed Critical Anglia Ruskin Univ Higher Education Corp

2021-07-01 Priority to GBGB2109534.4A priority Critical patent/GB202109534D0/en

2021-08-18 Publication of GB202109534D0 publication Critical patent/GB202109534D0/en

2022-06-22 Priority to PCT/EP2022/067071 priority patent/WO2023274817A1/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB2109534.4A 2021-07-01 2021-07-01 Treatment of scarring Ceased GB202109534D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB2109534.4A GB202109534D0 (en)	2021-07-01	2021-07-01	Treatment of scarring
PCT/EP2022/067071 WO2023274817A1 (en)	2021-07-01	2022-06-22	1-hydroxy-pyridin-2-one derivatives for use in the treatment of scarring

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB2109534.4A GB202109534D0 (en)	2021-07-01	2021-07-01	Treatment of scarring

Publications (1)

Publication Number	Publication Date
GB202109534D0 true GB202109534D0 (en)	2021-08-18

Family

ID=77274504

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB2109534.4A Ceased GB202109534D0 (en)	2021-07-01	2021-07-01	Treatment of scarring

Country Status (2)

Country	Link
GB (1)	GB202109534D0 (en)
WO (1)	WO2023274817A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999038541A1 (en)	1998-01-28	1999-08-05	The Procter & Gamble Company	Antimicrobial hydrogel forming absorbent polymers
CN106102775A (en) *	2014-02-07	2016-11-09	效应物治疗公司	The method for the treatment of fibrotic conditions
EP3927383A4 (en) *	2019-02-18	2022-11-09	Lankenau Institute for Medical Research	SCAR REDUCING WOUND CLOSURE MATERIALS
US20200352918A1 (en) *	2019-05-07	2020-11-12	Brigitte N. Gomperts	Compounds and methods for treating or preventing fibrosis

2021
- 2021-07-01 GB GBGB2109534.4A patent/GB202109534D0/en not_active Ceased
2022
- 2022-06-22 WO PCT/EP2022/067071 patent/WO2023274817A1/en active Application Filing

Also Published As

Publication number	Publication date
WO2023274817A1 (en)	2023-01-05

Publication	Publication Date	Title
IL315503A (en)	2024-11-01	Methods of treatment
GB202201819D0 (en)	2022-03-30	Methods of treatment
GB202201825D0 (en)	2022-03-30	Methods of treatment
GB202201824D0 (en)	2022-03-30	Methods of treatment
GB202109534D0 (en)	2021-08-18	Treatment of scarring
GB2595513B (en)	2023-03-29	Treatment of infections
GB202118011D0 (en)	2022-01-26	Methods of treatment
GB202118007D0 (en)	2022-01-26	Methods of treatment
GB202118006D0 (en)	2022-01-26	Methods of treatment
GB202108245D0 (en)	2021-07-21	Methods of treatment
GB202108242D0 (en)	2021-07-21	Methods of treatment
GB202315695D0 (en)	2023-11-29	TReatment of cariomyopathy
GB202005874D0 (en)	2020-06-03	Methods of treatment
GB202212506D0 (en)	2022-10-12	Treatment of covid-19
IL320711A (en)	2025-07-01	Methods of treatment
ZA202005856B (en)	2021-10-27	Treatment of infections
GB202101251D0 (en)	2021-03-17	Treatment of conditions
GB202014412D0 (en)	2020-10-28	Treatment of coronavirus
GB202107994D0 (en)	2021-07-21	Treatment of cancer
GB202018062D0 (en)	2020-12-30	Treatment of cancer
HUE070653T2 (en)	2025-06-28	Treatment of dysphagia
GB202008037D0 (en)	2020-07-15	Treatment of cancer
GB202102950D0 (en)	2021-04-14	Method of treatment
AU2021900740A0 (en)	2021-04-01	Combination Methods of Treatment
GB202018243D0 (en)	2021-01-06	Method of treatment

Legal Events

Date	Code	Title	Description
2023-02-01	AT	Applications terminated before publication under section 16(1)